Mark Waring

Mark Waring has a diverse work experience, with their most recent role being the Senior VP of US Operations at Noxopharm Limited since February 2018. Before that, they were a Partner at D&M Advisors LLC from March 2012. Mark also worked as a Senior Director of Quality & Compliance Consulting at Quintiles from January 2013 to September 2016. Prior to that, Mark held positions as Specialist Leader at Deloitte Consulting and Associate Director at Navigant Consulting. Mark has also worked at Quintiles as an Associate Director of Project Management. Mark began their career as the Director of Clinical and Technical Affairs at Novogen and also worked as a Senior Scientific Officer at the University of Sydney.

Mark Waring's education history includes a Bachelor of Science degree in Pharmacology/Biochemistry from the University of Sydney, which they obtained from 1982 to 1986. Prior to that, they completed their high school education at Normanhurst Boys High School from 1976 to 1981, where they obtained their High School Certificate (HSC). In addition to their formal education, Mark Waring has also obtained certifications such as the ASQ Pharmaceutical GMP Professional from ASQ in December 2014 and the PMP (Project Management Professional) certification from the Project Management Institute in July 2014.